ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
57.94
-1.73 (-2.90%)
Feb 21, 2025, 4:00 PM EST - Market closed
ANI Pharmaceuticals Employees
ANI Pharmaceuticals had 642 employees as of December 31, 2023. The number of employees increased by 42 or 7.00% compared to the previous year.
Employees
642
Change (1Y)
42
Growth (1Y)
7.00%
Revenue / Employee
$865,196
Profits / Employee
-$13,654
Market Cap
1.13B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ANIP News
- 2 days ago - ANI Pharmaceuticals to Present at Raymond James' Institutional Investors and Leerink Partners Global Healthcare Conferences in March - GlobeNewsWire
- 4 days ago - ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET - GlobeNewsWire
- 11 days ago - ANI Pharmaceuticals: More Than Just A Generics Company - Seeking Alpha
- 24 days ago - ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference - GlobeNewsWire
- 5 weeks ago - Alcami Announces CEO Transition - PRNewsWire
- 5 weeks ago - ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook - GlobeNewsWire
- 7 weeks ago - ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity - GlobeNewsWire
- 7 weeks ago - ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire